FDA OKs New Drug for Fast-Killing Leukemia

The Food and Drug Administration has approved a new medicine for use against a rare, rapidly progressing blood cancer after other treatments have failed. The agency approved Pfizer Inc.'s Besponsa for patients with a type of advanced acute lymphoblastic leukemia.